Greystone Managed Investments’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-30,518
Closed -$7.03M 86
2016
Q3
$7.03M Sell
30,518
-436
-1% -$107K 0.32% 70
2016
Q2
$7.15M Buy
30,954
+6,687
+28% +$1.54M 0.29% 64
2016
Q1
$6.5M Buy
24,267
+3,190
+15% +$913K 0.24% 67
2015
Q4
$6.59M Sell
21,077
-9,880
-32% -$2.94M 0.25% 66
2015
Q3
$8.41M Sell
30,957
-35,299
-53% -$10.8M 0.31% 59
2015
Q2
$20.1M Sell
66,256
-28,956
-30% -$8.64M 0.53% 40
2015
Q1
$28.3M Sell
95,212
-21,670
-19% -$6.18M 0.64% 40
2014
Q4
$30.1M Buy
116,882
+12,059
+12% +$3.01M 0.64% 38
2014
Q3
$25.3M Sell
104,823
-63,809
-38% -$14.3M 0.51% 52
2014
Q2
$37.6M Sell
168,632
-36,350
-18% -$7.53M 0.68% 29
2014
Q1
$42.2M Buy
+204,982
New +$40.6M 0.77% 26

Other funds holding AGN

Greystone Managed Investments's AGN Position: Q4 2016 in Review

Greystone Managed Investments sold out of Allergan plc (AGN) in Q4 2016, closing a stake of 30,518 shares — an estimated $7.03M sold.

Greystone Managed Investments first reported a position in AGN in Q1 2014 and held it in 11 quarters. The position peaked at $42.2M in Q1 2014. 1,091 funds tracked by Wall St. Rank hold AGN as of Q4 2016.

  • Greystone Managed Investments reported no remaining Allergan plc position as of Q4 2016 after selling out during the quarter.
  • Greystone Managed Investments sold 30,518 Allergan plc shares in Q4 2016, an estimated $7.03M.
  • Greystone Managed Investments first reported a position in Allergan plc in Q1 2014 and held it in 11 quarters.
  • Greystone Managed Investments's Allergan plc position peaked at $42.2M in Q1 2014.
  • 1,091 funds tracked by Wall St. Rank held Allergan plc as of Q4 2016.

Based on Greystone Managed Investments's 13F filing for Q4 2016, filed 14 Feb 2017.